Metformin: Uses and Side Effects

This post was written with Consensus AI Academic Search Engine – please read our Disclaimer at the end of this article. Metformin is a widely used medication primarily prescribed for the management of type 2 diabetes mellitus (T2DM). It is known for its efficacy in lowering blood glucose levels and improving insulin sensitivity. However, like any medication, metformin is associated with a range of side effects, some of which can impact patient adherence and overall treatment efficacy. This article explores the uses of metformin and its associated side effects, drawing on recent research findings.

Uses of Metformin

Management of Type 2 Diabetes

Metformin is the first-line oral glucose-lowering agent for individuals with T2DM. It works by decreasing hepatic glucose production, increasing insulin sensitivity, and enhancing peripheral glucose uptake1 2. Studies have shown that metformin not only helps in controlling blood sugar levels but also has beneficial effects on the gut microbiome, which may contribute to its therapeutic effects2.

Prevention of Metabolic Complications

Metformin has been found to prevent metabolic complications in patients undergoing systemic glucocorticoid treatment. In a double-blind, placebo-controlled trial, metformin was shown to maintain glycemic control and prevent the development of metabolic syndrome in non-diabetic patients receiving glucocorticoids3 8. This suggests that metformin could be a promising drug for preventing metabolic side effects during glucocorticoid therapy.

Weight Management in Antipsychotic-Induced Weight Gain

Metformin has also been investigated for its potential to manage weight gain induced by antipsychotic medications. A pilot study demonstrated that metformin was effective in controlling weight gain in patients with first-episode psychosis who were on antipsychotic treatment5. This highlights its potential use beyond diabetes management.

Side Effects of Metformin

Gastrointestinal Side Effects

One of the most common side effects of metformin is gastrointestinal (GI) intolerance, which includes symptoms such as diarrhea, nausea, and abdominal discomfort. These side effects can limit the titration to an efficacious dose or cause discontinuation of the medication1 5 6. Research has shown that the addition of a gastrointestinal microbiome modulator (GIMM) to metformin can improve tolerance and reduce GI symptoms, allowing for better adherence to the medication6.

Cardiovascular Effects

Metformin has been associated with both neuroprotective and neurodegenerative effects. A study investigating the combination of metformin and insulin found that metformin increased the early drop in orthostatic blood pressure, indicating an adverse effect on cardiovascular autonomic neuropathy (CAN)4. However, another study found that metformin did not adversely affect hormonal and symptomatic responses to hypoglycemia, suggesting that it is safe to use in combination with insulin therapy7.

Impact on Gut Microbiome

Metformin significantly alters the gut microbiome, which may mediate some of its antidiabetic effects. A study demonstrated that metformin-treated individuals showed distinct shifts in their gut microbiota, which were associated with improved glucose tolerance2. This interaction between metformin and the gut microbiome is an area of ongoing research and may provide insights into optimizing metformin therapy.

Other Side Effects

Metformin has been shown to have protective effects against diabetic retinopathy by suppressing the toll-like receptor 4/nuclear factor-kappa B (TLR4/NFkB) pathway and reducing oxidative stress10. Additionally, metformin did not affect N-terminal pro B-type natriuretic peptide (NT-proBNP) levels, indicating that its cardioprotective effects are not mediated through changes in cardiac pressures or volumes9.

Conclusion

Metformin remains a cornerstone in the management of type 2 diabetes due to its efficacy in lowering blood glucose levels and its additional benefits in preventing metabolic complications and managing weight gain. However, its use is not without side effects, particularly gastrointestinal intolerance and potential cardiovascular impacts. Ongoing research into the interaction between metformin and the gut microbiome, as well as strategies to mitigate its side effects, will continue to enhance its therapeutic profile and patient adherence.

Disclaimer

The content presented in this blog is generated by Consensus, an AI-powered academic search engine, and is based on publicly available scientific literature. While every effort is made to provide accurate, up-to-date, and well-researched information, the content is intended for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making any decisions regarding medical conditions, treatments, or medications. The AI system’s analysis may not cover all perspectives, emerging research, or individual cases, and it is not a substitute for professional expertise. Neither the blog publisher nor the developers of the AI-powered search engine are responsible for any actions taken based on the information provided in this content. Use of this information is at your own risk. Citations to the original scientific studies are included for reference, but these studies should be reviewed in full and interpreted with the guidance of a healthcare or research professional.

If you are experiencing a medical emergency, please seek immediate attention from a healthcare provider.